Functional Properties of the Nicotinic and Glutamatergic Receptors

References

• Neher E., Sakmann B. Single channel currents recorded from membrane of denervated frog muscle fibers. Nature 1976; 260: 799–802
   PubMed Web of Science ®Google Scholar
• Hamill O. P., Marty A., Neher E., Sakmann B., Sigworth F. J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 1981; 391: 85–100
   PubMed Web of Science ®Google Scholar
• Albuquerque E. X., Alkondon M., Lima-Landman M. T., Deshpande S. S., Ramoa A. S. Molecular targets of noncompetitive blockers at the central and peripheral nicotinic and glutamatergic receptors. Neuromuscular Junction, L. C. Selinn, R. Libelius, S. Thesleff, 1988; 273–300
   Google Scholar
• Aracava Y., Deshpande S. S., Swanson K. L., Rapoport H., Wonnacott S., Lunt G., Albuquerque E. X. Nicotinic acetylcholine receptors in cultured neurons from the hippocampus and brain stem of the rat characterized by single channel recording. FEBS Lett. 1987; 222: 63–70
   PubMed Web of Science ®Google Scholar
• Brown T. H., Ganong A. H., Kairiss E. W., Keenan C. L., Kelso S. R. Long-term potentiation in two synaptic systems of the hippocampal brain slice. Neural Models of Plasticity. Experimental and Theoretical Approaches, J. Byrne, W. O. Berry. Academic Press, San Diego, California 1989; 266–306
   Google Scholar
• Zucker R. S. Models of calcium regulation in neurons. Neural Models of Plasticity. Experimental and Theoretical Approaches, J. Byrne, W. O. Berry. Academic Press, San Diego, California 1989; 403–422
   Google Scholar
• Ramoa A. S., Alkondon M., Aracava Y., Irons J., Lunt G. G., Deshpande S. S., Wonnacott S., Albuquerque E. X. The anticonvulsant MK-801 blocks peripheral and central nicotinic acetylcholine receptor ion channels. J. Pharmacol. Exp. Ther. 1990, in press
   PubMedGoogle Scholar
• Collingridge G. L. Long term potentiation in the hippocampus: Mechanisms of initiation and modulation by neurotransmitters. Trends Pharmacol. Sci. 1985; 6: 407–411
   Web of Science ®Google Scholar
• Greenamyre J. T., Penney J. B., Young A. B., D'Amato C. J., Hicks S. P., Shoulson I. Alterations in l-glutamate binding in Alzheimer's and Huntington's diseases. Science 1985; 227: 1496–1499
   PubMed Web of Science ®Google Scholar
• Whitehouse P. J., Martino A. M., Antuono P. H., Lowenstein P. R., Coyle J. T., Price D. L., Kellar K. J. Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res. 1986; 371: 146–151
   PubMed Web of Science ®Google Scholar
• Hanke W., Breer H. Channel properties of an insect neuronal acetylcholine receptor protein reconstituted into planar lipid bilayers. Nature 1986; 321: 171–174
   PubMedGoogle Scholar
• Albuquerque E. X., Daly J., Warnick J. E. Macromolecular sites for specific neurotoxins and drugs on chemosensitive synapses and electrical excitation in biological membranes. Ion Channels, T. Narahashi. Plenum Press, New York 1988; 95–162
   Google Scholar
• Spivak C. E., Witkop B., Albuquerque E. X. Anatoxin-a: A novel, potent agonist at the nicotinic receptor. Mol. Pharmacol. 1980; 18: 382–394
   Google Scholar
• Swanson K. L., Allen C. N., Aronstam R. S., Rapoport H., Albuquerque E. X. Molecular mechanisms of the potent and stereospecific nicotinic receptor agonist (+)-anatoxin-a. Mol. Pharmacol. 1986; 29: 250–257
   PubMed Web of Science ®Google Scholar
• Aracava Y., Swanson K. L., Rozental R., Albuquerque E. X. Structure-activity relationships of (+)anatoxin-a derivatives and enantiomers of nicotine on the peripheral and central nicotinic acetylcholine receptor subtypes. Neurotox 88: Molecular Basis of Drug and Pesticide Action, G. G. Lunt. Elsevier Science Publishers, Cambridge 1988; 157–184
   Google Scholar
• Eldefrawi M. E., Aronstam R. S., Bakry N. M., Eldefrawi A. T., Albuquerque E. X. Perhydrohistrionicotoxin: A potential ligand for the ion conductance modulator of the acetycholine receptor. Proc. Natl. Acad. Sci. USA 1980; 77: 2309–2313
   PubMedGoogle Scholar
• Lima-Landman M. T., Albuquerque E. X. The novel neurotoxin perhydrohistrionicotoxin (H12HTX) blocks the N-methyl-d-aspartate (NMDA) receptor of cultured hippocampus of the rat. Soc. Neurosci. Abstr. 1988; 14: 96
   Google Scholar
• Lima-Landman M. T., Albuquerque E. X. Ethanol potentiates and blocks NMDA-activated single channel currents in rat hippocampal pyramidal cells. FEBS Lett. 1989; 247: 61–67
   PubMed Web of Science ®Google Scholar
• Alkondon M., Costa A. C.S., Radhakrishnan V., Aronstam R. S., Albuquerque E. X. Selective blockade of NMDA-activated channel currents may be implicated in learning deficits caused by lead. FEBS Lett. 1990; 261: 124–130
   PubMed Web of Science ®Google Scholar
• Allen C. N., Akaike A., Albuquerque E. X. The frog interosseal muscle fiber as a new model for patch clamp studies of chemosensitive and voltage-sensitive ion channels: actions of acetylcholine and batrachotoxin. J. Physiol. (Paris) 1984; 79: 338–343
   PubMedGoogle Scholar
• Ramoa A. S., Campbell G., Shatz C. J. Transient morphological features of identified ganglion cells in living fetal and neonatal retina. Science 1987; 237: 522–525
   PubMedGoogle Scholar
• Katz L. C. Local circuitry of identified projection neurons in cat visual cortex brain slices. J. Neurosci. 1987; 7: 1223–1249
   PubMed Web of Science ®Google Scholar
• Boycott B. B., Wassle H. The morphological types of ganglion cells of the domestic cat's retina. J. Physiol. (Lond.) 1974; 240: 397–420
   Google Scholar
• Perry V. H. The ganglion cell layer of the retina of the rat: a Golgi study. Proc. R. Soc. Lond. B 1979; 204: 353–375
   Google Scholar
• Alkondon M., Albuquerque E. X. The non-oxime bispyridinium compound SAD-128 alters the kinetic properties of the AChR ion channel: A possible mechanism for antidotal effects. J. Pharmacol. Exp. Ther. 1989; 250: 842–852
   PubMed Web of Science ®Google Scholar
• Rozental R., Aracava Y., Scoble G. T., Swanson K. L., Wonnacott S., Albuquerque E. X. The recognition sites of the nicotinic acetylcholinc receptor differentiate the stereoisomers of nicotine. J. Pharmacol. Exp. Ther. 1989; 251: 395–404
   PubMedGoogle Scholar
• Krishtal O. A., Pidoplichko V. I. A receptor for protons in the nerve cell membrane. Neurosci. 1980; 5: 2325–2327
   PubMed Web of Science ®Google Scholar
• Fenwick E. M., Marty A., Neher E. A patch-clamp study of bovine chromaffin cells and of their sensitivity to acetylcholine. J. Physiol. (Lond.) 1982; 331: 577–597
   Google Scholar
• Beers W. H., Reich E. Structure and activity of acetylcholine. Nature 1970; 288: 917–922
   Google Scholar
• Kofuji P., Aracava Y., Swanson K. L., Aronstam R. S., Rapoport H., Albuquerque E. X. Ion channel activation and blockade by the nicotinic agonist (+) anatoxin-a, the N-melthyl derivative and the enantiomer. J. Pharmacol. Exp. Ther. 1990; 252: 517–525
   PubMedGoogle Scholar
• Costa A. C. S., Swanson K. L., Aracava Y., Aronstam R. S., Albuquerque E. X. Molecular effects of dimethylanatoxin on the peripheral nicotinic acetylcholine receptor. J. Pharmacol. Exp. Ther. 1990; 252: 507–516
   PubMedGoogle Scholar
• Karlin A. Molecular properties of nicotinic acctylcholine receptors. The Cell Surface and Neuronal Function, C. W. Cotman, G. Poste, G. L. Nicholson. Elsevier-North Holland Biomedical Press, New York 1980; 191–260
   Google Scholar
• Spivak C. E., Albuquerque E. X. Dynamic properties of the nicotinic acetylcholine receptor ionic channel complex: activation and blockade. Progress in Cholinergic Biology: Model Cholinergic Synapses, I. Hanin, A. Goldberg. Raven Press, NY 1982; 323–357
   Google Scholar
• Changeux J.-P. Functional architecture and dynamics of the nicotinic acetylcholine receptor: An allosteric ligand-gated ion channel. 1988–1989 Fidia Research Foundation: Rita Levi-Montalcini Neuroscience Award Lecture. 1990
   Google Scholar
• Varanda W. A., Aracava Y., Sherby S. M., Van Meter W. G., Eldefrawi M. E., Albuquerque E. X. The acetylcholine receptor of the neuromuscular junction recognizes mecamylamine as a noncompetitive antagonist. Mol. Pharmacol. 1985; 28: 128–137
   PubMed Web of Science ®Google Scholar
• Daly J. W., Spande T. F. Chemistry, pharmacology and biology of alkaloids from amphibians. Alkaloids: Chemical and Biological Perspectives, S. W. Pelletier. Wiley, New York 1986; Vol. 4: 1–275
   Google Scholar
• Spivak C. E., Maleque M. A., Oliveira A. C., Masukawa L. M., Tokuyama T., Daly J. W., Albuquerque E. X. Actions of histrionicotoxins at the ion channel of the nicotinic acetylcholine receptor and at the voltage-sensitive ion channels of muscle membranes. Mol. Pharmacol. 1982; 211: 351–361
   Google Scholar
• Albuquerque E. X., Kuba K., Daly J. Effect of histrionicotoxin on the ionic conductance modulator of the cholinergic receptor: A quantitative analysis of the endplate current. J. Pharmacol. Exp. Ther. 1974; 189: 513–524
   PubMed Web of Science ®Google Scholar
• Schofield G. G., Witkop B., Warnick J. E., Albuquerque E. X. Differentiation of the open and closed states of the ionic channels of nicotinic acetylcholine receptors by tricyclic antidepressants. Proc. Natl. Acad. Sci. USA 1981; 78: 5240–5244
   PubMed Web of Science ®Google Scholar
• Carp J. S., Aronstam R. S., Witkop B., Albuquerque E. X. Proc. Natl. Acad. Sci. USA Electrophysiological and biochemical studies on enhancement of desensitization by phenothiazine neuroleptics. 1983; 80: 310–314
   Google Scholar
• Reis R. A.M., Costa A. C. S., Himel C. M., Albuquerque E. X. Acridine and acridine araphane compounds as molecular tools in the study of channel kinetics and homology. Biophys. J. 1990; 57: 286a
   Google Scholar
• Shaw K.-P., Silveira F. C. A., Aronstam R. S., Albuquerque E. X. A new class of cholinergic antagonists: Acridine araphanes have a high affinity to muscarinic receptors. Soc. Neurosci. Abstr. 1990, in press
   Google Scholar
• Aguayo L. G., Albuquerque E. X. Effects of phencyclidine and its analogs on the end-plate current of the neuromuscular junction. J. Pharmacol. Exp. Ther. 1986; 239: 25–31
   PubMedGoogle Scholar
• Albuquerque E. X., Aguayo L. G., Warnick J. E., Weinstein H., Glick S. D., Maayani S., Ickowicz R. K., Blaustein M. P. The behavioral effects of phencyclidines may be due to their blockade of potassium channels. Proc. Natl. Acad. Sci. USA 1981; 78: 7792–7796
   PubMedGoogle Scholar
• Aguayo L. G., Albuquerque E. X. Phencyclidine blocks two potassium currents in spinal neurons in cell culture. Brain Res. 1987; 436: 9–17
   PubMedGoogle Scholar
• Albuquérque E. X., Warnick J. E., Aguayo L. G. Phencyclidine: Differentiation of behaviorally active from inactive analogs based on interactions with channels of electrically excitable membranes and of cholinergic receptors. Phencyclidines and Related Arylcyclohexylamines, Present and Future Application, J. M. Kamenka, E. F. Domino, P. Geneste, N. P.P. Books, Ann Arbor, MI 1983; 579–594
   Google Scholar
• Wada K., Ballivet M., Boulter J., Connolly J., Wada E., Deneris E. S., Swanson L. W., Heinemann S., Patrick J. Functional expression of a new pharmacological subtype of brain nicotinic AChR. Science 1988; 240: 330–334
   PubMed Web of Science ®Google Scholar
• MacAllan D. R. E., Lunt G. G., Wonnacott S., Swanson K. L., Rapoport H., Albuquerque E. X. Methyllycaconitine and (+)-anatoxin-a differentiate between nicotinic receptors in vertebrate and invertebrate nervous systems. FEBS Lett. 1988; 226: 357–363
   PubMed Web of Science ®Google Scholar
• Rapier C., Lunt G. G., Wonnacott S. Stereoselective nicotine-induced release of dopamine from striatal synaptosomes: concentration dependence and repetitive stimulation. J. Neurochem. 1988; 50: 1123–1130
   PubMedGoogle Scholar
• Mulle C., Changeux J.-P. A Novel type of nicotinic receptor in the rat central nervous system characterized by patch-clamp techniques. J. Neurosci. 1990; 10: 169–175
   PubMed Web of Science ®Google Scholar
• Alkondon M., Albuquerque E. X. Nicotinic acetylcholine receptor (nAChR) ion channel currents in rat hippocampal neurons. Soc. Neurosci. Abstr. 1990, in press
   Google Scholar
• Yamasaki E. N., Rocha M. S., Ramoa A. S. Morphology of rat retinal ganglion cells during fetal and postnatal development. Soc. Neurosci. Abstr. 1989; 15: 455
   Google Scholar
• Ramoa A. S., Albuquerque E. X. Phencyclidine and some of its analogues have distinct effects on NMDA receptors of rat hippocampal neurons. FEBS Lett. 1988; 235: 156–162
   PubMedGoogle Scholar
• Siqueira-Rocha E., Albuquerque E. X., Ramoa A. S. Effects of sigma ligands on NMDA-induced single channel currents. Soc. Neurosci. Abstr. 1990, in press
   Google Scholar
• Anis N. A., Berry S. C., Burton N. R., Lodge D. The dissociative anesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br. J. Pharmacol. 1983; 79: 565–575
   PubMed Web of Science ®Google Scholar
• Harrison N. L., Simmonds M. A. Quantitative studies on some antagonists of N-methyl aspartate in slices of rat cerebral cortex. Br. J. Pharmacol. 1985; 84: 381–391
   PubMed Web of Science ®Google Scholar
• Honey C. R., Miljkovic Z., MacDonald J. F. Ketamine and Phencyclidine cause a voltage dependent block of responses to L-aspartic acid. Neurosci. Lett. 1985; 61: 135–139
   PubMedGoogle Scholar
• Martin D., Lodge D. Ketamine acts as a noncompctitive NMDA antagonist on frog spinal cord in vitro. Neuropharmacol. 1985; 24: 999–1003
   PubMedGoogle Scholar
• Wong E. H. F., Kemp J. A., Priestley T., Knight A. R., Woodruff G. N., Iversen L. L. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. USA 1986; 47: 7104–7108
   Google Scholar
• Foster A. C., Fagg G. E. Taking apart NMDA receptors. Nature 1987; 329: 395–396
   PubMed Web of Science ®Google Scholar
• Maleque M. A., Warnick J. E., Albuquerque E. X. The mechanism and site of action of ketamine on skeletal muscle. J. Pharmacol. Exp. Ther. 1981; 219: 638–645
   PubMedGoogle Scholar
• Summers W. K., Majovski L. V., Marsh G. M., Tachiki K., Kling A. Oral tetrahydroaminoacridine in long-term treatment of senile dementia. Alzheimer type. New England J. Med. 1986; 315: 1241–1245
   PubMed Web of Science ®Google Scholar
• Gauthier S., et al. Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage alzheimer's disease. New England J. Med. 1990; 322: 1272–1276
   PubMed Web of Science ®Google Scholar